Impaired Response To First Sars-Cov-2 Dose Vaccination In Myeloproliferative Neoplasm Patients Receiving Ruxolitinib

AMERICAN JOURNAL OF HEMATOLOGY(2021)

引用 30|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要